Kiromic Biopharma, Inc. Contracts & Agreements

106 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Exchange Agreement dated as of November 1, 2024 between the Company and the holder of the Exchange Notes
Exchange Agreements
Kiromic Biopharma, Inc.
2024
Form of Exchange Agreement dated as of September 27, 2024 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
2024
Executive Employment Agreement Amendment dated as of August 7, 2024 by and between Kiromic Biopharma, Inc. and Brian Hungerford
Employment Agreements
Kiromic Biopharma, Inc.
2024
25% Senior Secured Convertible Promissory Note, dated August 1, 2024
Note Agreements
Kiromic Biopharma, Inc.
2024
25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
First Amendment to 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Exchange Agreement dated as of June 21, 2024 between the Company and the Holder
Exchange Agreements
Kiromic Biopharma, Inc.
2024
25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Form of Exchange Agreement dated as of March 28, 2024 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2024
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Executive Employment Agreement dated as of October 1, 2023 by and between Kiromic Biopharma, Inc. and Brian Hungerford
Employment Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of Exchange Agreement dated as of July 18, 2023 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of Exchange Agreement dated as of March 28, 2023 between the Company and the holder of the Exchange Securities
Exchange Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Form of Note Purchase Agreement
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2023
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
2023
Separation Agreement between Daniel Clark and Kiromic BioPharma, Inc. dated December 27, 2022
Separation Agreements
Kiromic Biopharma, Inc.
2022
Form of the Amended and Restated 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties
Settlement Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties
Warrant Agreements
Kiromic Biopharma, Inc.
2022
Form of the 25% Senior Secured Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Standby Equity Purchase Agreement, dated October 13, 2022, by and between Kiromic Biopharma, Inc. and YA II PN, Ltd
Purchase Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties
Settlement Agreements
Kiromic Biopharma, Inc.
2022
Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties
Warrant Agreements
Kiromic Biopharma, Inc.
2022
Form of the Subordinated Convertible Promissory Note
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of Underwriting Agreement
Underwriting Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of Common Stock Warrants
Stock Agreements
Kiromic Biopharma, Inc.
2022
Form of Warrant Agent Agreement
Warrant Agreements
Kiromic Biopharma, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Form of Representatives Warrant
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
2022
Executive Employment Agreement effective as of July 11, 2022, by and between Kiromic BioPharma, Inc. and Dr. Leonardo Mirandola
Employment Agreements
Kiromic Biopharma, Inc.
2022
Form of Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement
Non-Competition Agreements
Kiromic Biopharma, Inc.
2022
First Amendment to Executive Employment Agreement effective as of May 10, 2022, by and between Kiromic BioPharma, Inc. and Pietro Bersani
Employment Agreements
Kiromic Biopharma, Inc.
2022
First Amendment to Executive Employment Agreement effective as of May 10, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark
Employment Agreements
Kiromic Biopharma, Inc.
Biotechnology
2022
Description of Securities
Kiromic Biopharma, Inc.
2022
Transition and Consulting Agreement effective as of February 9, 2022, by and between Kiromic BioPharma, Inc. and Gianluca Rotino
Consulting Agreements
Kiromic Biopharma, Inc.
2022
Modification to Employment Agreement effective as of February 9, 2022, by and between Kiromic BioPharma, Inc. and Scott Dahlbeck
Employment Agreements
Kiromic Biopharma, Inc.
2022
Executive Employment Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark
Employment Agreements
Kiromic Biopharma, Inc.
Biotechnology
TX
2022
Confidential Information, Inventions, Non-Solicitation, and Non-Competition Agreement effective as of February 14, 2022, between Kiromic BioPharma, Inc. and Daniel Clark
Non-Competition Agreements
Kiromic Biopharma, Inc.
2022
Indemnification Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark
Indemnification Agreements
Kiromic Biopharma, Inc.
2022
Executive Employment Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani
Employment Agreements
Kiromic Biopharma, Inc.
2022
Confidential Information, Inventions, Non-Solicitation, and Non-Competition Agreement effective as of January 27, 2022 between Kiromic BioPharma, Inc. and Pietro Bersani
Non-Competition Agreements
Kiromic Biopharma, Inc.
Biotechnology
TX
2022
Indemnification Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani
Indemnification Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2022
Separation Agreement dated as of December 6, 2021 between Kiromic Biopharma, Inc. and Ignacio Nunez
Separation Agreements
Kiromic Biopharma, Inc.
2021
Executive Employment Agreement by and between the Company and Dr. Michael Ryan, effective as of July 1, 2021
Employment Agreements
Kiromic Biopharma, Inc.
2021
Form of Underwriting Agreement
Underwriting Agreements
Kiromic Biopharma, Inc.
2021
Form of Representatives Warrant
Warrant Agreements
Kiromic Biopharma, Inc.
Biotechnology
2021
Fifth Amendment to Lease Agreement, dated December 2, 2020, between Cambridge Properties and Kiromic BioPharma, Inc
Lease Agreements
Kiromic Biopharma, Inc.
2021
Sixth Amendment to Lease Agreement, dated March 22, 2021, between Cambridge Properties and Kiromic BioPharma, Inc
Lease Agreements
Kiromic Biopharma, Inc.
2021
Membership Interest Purchase Agreement dated as of June 14, 2021 among Kiromic BioPharma, Inc., In Silico Solution, LLC and Michael Ryan
Purchase Agreements
Kiromic Biopharma, Inc.
2021
Executive Employment Agreement by and between the Company and Mr. Ignacio Nunez, effective as of June 7, 2021
Employment Agreements
Kiromic Biopharma, Inc.
2021
Letter of Intent, dated April 8, 2021
Kiromic Biopharma, Inc.
2021
Description of Securities
Kiromic Biopharma, Inc.
Biotechnology
2021
Strategic Alliance Agreement by and between the Company and Leon Office (H.K.) Ltd, effective as of January 28, 2021
Kiromic Biopharma, Inc.
Biotechnology
TX
2021
Amended and Restated License Agreement by and between the Company and Longwood University, dated as of November 30, 2020
License Agreements
Kiromic Biopharma, Inc.
Biotechnology
2021
Form of Representatives Warrant Agreement
Warrant Agreements
Kiromic Biopharma, Inc.
2020
Underwriting Agreement, dated October 15, 2020
Underwriting Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2020
Form of Underwriting Agreement
Underwriting Agreements
Kiromic Biopharma, Inc.
2020
Form of Representatives Warrant
Warrant Agreements
Kiromic Biopharma, Inc.
2020
Employment Agreement, to be effective upon the initial public offering, between Kiromic BioPharma, Inc. and Tony Tontat
Employment Agreements
Kiromic Biopharma, Inc.
Biotechnology
TX
2020
Employment Agreement dated January 1, 2020 between Kiromic BioPharma, Inc and Scott Dahlbeck
Employment Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Employment Agreement, to be effective upon the initial public offering, between Kiromic BioPharma, Inc. and Gianluca Rotino
Employment Agreements
Kiromic Biopharma, Inc.
2020
Employment Agreement, to be effective upon the initial public offering, between Kiromic BioPharma, Inc. and Maurizio Chiriva Internati
Employment Agreements
Kiromic Biopharma, Inc.
2020
Form of Director Services Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors
Services Agreements
Kiromic Biopharma, Inc.
2020
Form of Director Indemnification Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors
Indemnification Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
Form of Warrant to Purchase Common Stock
Warrant Agreements
Kiromic Biopharma, Inc.
2020
Series B Preferred Stock Purchase Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc. and certain investors
Stock Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
Investors Rights Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc. and certain investors
Investor Rights Agreements
Kiromic Biopharma, Inc.
2020
Right of First Refusal and Co-Sale Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc., certain investors and certain stockholders
Kiromic Biopharma, Inc.
2020
Voting Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc., certain investors and certain stockholders
Voting Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
Form of Securities Purchase Agreement for Series A-1 Preferred Stock
Stock Agreements
Kiromic Biopharma, Inc.
2020
Convertible Promissory Note issued by Kiromic BioPharma, Inc. to Prevail Partners on May 30, 2019
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
Form of 17% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors
Note Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
Form of 7% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors
Note Agreements
Kiromic Biopharma, Inc.
2020
Stockholders Agreement, dated May 27, 2016, among Kiromic BioPharma, Inc. and certain stockholders
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
License Agreement, dated December 1, 2016, between Mercer University and Kiromic BioPharma, Inc
License Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2020
License Agreement, dated September 14, 2018, between CGA 369 Intellectual Holdings, Inc. and Kiromic BioPharma, Inc
License Agreements
Kiromic Biopharma, Inc.
2020
Amendment to License Agreement, dated October 16, 2019, between CGA 369 Intellectual Holdings, Inc. and Kiromic BioPharma, Inc
License Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Collaboration Agreement, dated February 4, 2019, between University of Texas MD Anderson Cancer Center and Kiromic BioPharma, Inc
Collaboration Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Collaboration Agreement, dated February 6, 2020, between University of Texas MD Anderson Cancer Center and Kiromic BioPharma, Inc
Collaboration Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Lease Agreement, dated October 9, 2015, between Timothy L. Sharma d/b/a Cambridge Properties and Kiromic, Inc
Lease Agreements
Kiromic Biopharma, Inc.
2020
Second Amendment to Lease Agreement, dated May 6, 2016, between Cambridge Properties and Kiromic, Inc
Lease Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Third Amendment to Lease Agreement, dated November 7, 2018, between Cambridge Properties and Kiromic, Inc
Lease Agreements
Kiromic Biopharma, Inc.
2020
Fourth Amendment to Lease Agreement, dated October 8, 2019, between Cambridge Properties and Kiromic, Inc
Lease Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Employment Agreement, dated March 20, 2016, between Kiromic, Inc. and Maurizio Chiriva Internati
Employment Agreements
Kiromic Biopharma, Inc.
Biotechnology
TX
2020
Addendum to Employment Agreement, dated March 20, 2016, between Kiromic, Inc. and Maurizio Chiriva Internati
Employment Agreements
Kiromic Biopharma, Inc.
2020
Consulting Agreement, dated November 2, 2018, between Kiromic, Inc. and Scott Dahlbeck
Consulting Agreements
Kiromic Biopharma, Inc.
2020
Addendum to Consulting Agreement, dated August 1, 2019, between Kiromic, Inc. and Scott Dahlbeck
Consulting Agreements
Kiromic Biopharma, Inc.
2020
Consulting Agreement, dated July 20, 2018, between Kiromic, Inc. and Gianluca Rotino
Consulting Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Addendum to Consulting Agreement, dated August 1, 2019, between Kiromic, Inc. and Gianluca Rotino
Consulting Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Kiromic, Inc. 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
Joint venture agreement, dated 4.06.2020, between Molipharma S.R.L. and Kiromic BioPharma, Inc
Joint Venture Agreements
Kiromic Biopharma, Inc.
2020